SkinBioTherapeutics PLC (SBTX)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
22.50p
Buy
23.00p
-1.00p (-4.21%)
Prices updated at 21 Mar 2025, 16:09 GMT
| Prices minimum 15 mins delay
Prices in GBX
SkinBioTherapeutics PLC is a life science company. The company is engaged in the development of technology to protect, manage and restore skin utilising proteins found in human microbiota.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 132,057 | 1m | |
| 85,190 | 683,038 | |
| -3m | -3m | |
| -2,237.77 | -239.64 | |
| -3m | -3m | |
| -3m | -3m | |
| Sales, General and administrative | 118,744 | 241,022 |
| Interest expenses | 17,772 | 51,401 |
| Provision for income taxes | -173,089 | -72,902 |
| Operating expenses | 3m | 4m |
| Income before taxes | -3m | -3m |
| Net income available to common shareholders | -3m | -3m |
| -0.0165 | -0.0154 | |
| Net interest income | -17,772 | -51,401 |
| Advertising and promotion | - | - |
| Net investment income, net | 51 | -1,041 |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | -0.0165 | -0.0154 |
| Free cash flow per share | -0.0171 | -0.0157 |
| Book value/share | 0.0105 | 0.013 |
| Debt equity ratio | 0.034889 | 0.013422 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 2m | 2m |
| Current liabilities | 529,741 | 2m |
| Total capital | 2m | 3m |
| Total debt | 100,646 | 818,742 |
| Total equity | 2m | 3m |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 3m | 5m |
| Total liabilities | - | - |
| Cash and cash equivalents | 1m | 800,904 |
| Common stock | 173m | 202m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 2m | 1m |
| Cash dividends paid | - | - |
| -3m | -3m | |
| Investments (gains) losses | -165,277 | -2m |
| 1m | 800,904 | |
| Net income | - | - |
| -3m | -3m | |
| -165,277 | -198,169 |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
